Using telemedicine to manage depression
Randomized Multicenter Clinical Trial of the Efficacy of a Telemedicine Monitoring in the Management of a Depressive Episode After an Hospitalisation in Medicine or Surgery
This study is testing if telemedicine sessions can help hospitalized patients with depression stick to their treatment and feel better after their medication changes.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 836 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Assistance Publique - Hôpitaux de Paris Academic / other |
| Locations | 1 site (Paris) |
| Trial ID | NCT06076317 on ClinicalTrials.gov |
What this trial studies
This study evaluates the effectiveness of telemedicine sessions in managing Major Depressive Disorder (MDD) among patients hospitalized in France. It aims to improve treatment adherence and secondary prevention by providing ongoing support and monitoring through telemedicine. The study focuses on patients who have recently had changes in their psychotropic medications during their hospital stay. By assessing symptomatology and treatment responses, the study seeks to optimize care pathways for MDD patients.
Who should consider this trial
Good fit: Ideal candidates are adults aged 18 and older who meet the DSM5 criteria for a characterized depressive episode and are currently hospitalized with a request for psychiatric consultation.
Not a fit: Patients with severe depressive episodes requiring inpatient psychiatric care or those currently enrolled in a psychiatric care program may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could lead to improved management of depression and better patient outcomes through enhanced treatment adherence.
How similar studies have performed: Previous studies have shown the effectiveness of telemedicine in managing depressive symptoms, although this specific approach has not been tested within French care pathways.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age ≥ 18 years * Presence of DSM5 criteria for the diagnosis of a characterized depressive episode * Patient hospitalized in MCO with request for liaison psychiatry opinion whatever the hospitalization modality (full hospitalization, weekday hospitalization or day hospitalization) * Initiation, change of molecule or modification of a psychotropic treatment (antidepressant or anxiolytic) during MCO hospitalization by the liaison psychiatrist * Affiliated or entitled to a social security system (except AME) * Obtaining free, written and informed consent Exclusion Criteria: * Severity of the depressive episode incompatible with outpatient care and relevant to an indication for hospitalization in psychiatry * Patient is part of a psychiatric care program at the time of the selection visit * Presence of a mood disorder other than CDD * Reason for MCO hospitalization secondary to psychiatric disorders, in particular suicide attempts * MCO hospitalization prolonged beyond 3 weeks after initiation, change of molecule or modification of psychotropic treatment dosage * Psychiatric comorbidities assessed by psychiatrist, in particular addictions (excluding tobacco), delusional disorders, post-traumatic stress disorder, anxiety disorders (excluding GAD) * High suicidal risk at the screening visit assessed by psychiatrist * Presence of a non-psychiatric condition with a vital prognosis of less than 3 years * Contraindications to telemedicine (no internet access, major vision problems, major cognitive problems, marked impulsivity, clinical situation requiring information to be communicated in person, etc.) * Conditions making consent impossible (major cognitive disorders, etc.) * Deprived of liberty or under a protective measure (guardianship or under curatorship) * Pregnant woman * Refusal of the patient
Where this trial is running
Paris
- Hôpital Pitié Salpêtrière — Paris, France (Recruiting)
Study contacts
- Principal investigator: Jean Yves ROTGE, Pr — Hôpital Pitié Salpêtrière - Assistance Publique Hôpitaux de Paris
- Study coordinator: Jean Yves ROTGE, Pr
- Email: jeanyves.rotge@aphp.fr
- Phone: 01 42 16 28 62
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.